Such dysregulation results in sustained elevations in cortisol and corticotropin-releasing factor (CRF), both of which contribute to systemic inflammation, endothelial dysfunction, and metabolic derangements that promote atherogenesis. Here, CRH is linked to endothelial dysfunction.